Thoracic Pathology

  • Continuing Education
Doctor shows results to old patient x-ray of the lungs, smoking cigarettes problem. Doctor explaining lungs x-ray on Tablet PC screen to young patient. Doctor showing female patient x-ray shot in clinic office. Coronavirus chest X-ray.

-

Registration Deadline: October 3

Provide a comprehensive overview of thoracic pathology by integrating clinical, radiologic, and molecular perspectives to enhance diagnostic accuracy. Highlight a multidisciplinary, case-based virtual learning approach that updates clinicians on modern techniques including morphologic analysis, immunohistochemistry, and molecular diagnostics.

  • Live Online

This course is taught online in real time.

 

Additionally, all sessions will be recorded and made available to participants for online viewing for 90 days after the end of the course.

$400 Save with early registration

For a full list of profession pricing see below.
View All

Fee increases to $500 after

Continuing Education

Earn up to:
15.00 AMA PRA Category 1 Credit(s) ™
View All

Two Days

Please view the Schedule for a full description of the program.

On This Page

Overview

This course, co-directed by Dr. Mino-Kenudson at Massachusetts General Hospital, Boston, and Dr. William Travis at Memorial Sloan Kettering Cancer Center, New York, presents a broad over-view of thoracic pathology with clinical, radiologic, and molecular correlation. It has been sponsored by Massachusetts General Hospital and Memorial Sloan Kettering Cancer Center. The course is designed to provide updates on thoracic pathology and aids in diagnosis based on conventional morphologic analysis as well as immunohistochemistry and molecular analyses. The program features conventional didactic lectures with frequent and extensive discussion periods and case-based presentations, including some multidisciplinary sessions, in a virtual format.

The faculty consist of thoracic and molecular pathologists, thoracic radiologists, surgeons, and oncologists, and pulmonologists from Massachusetts General Hospital, Brigham and Women’s Hospital, Memorial Sloan Kettering Cancer Center, and other academic medical centers, who have known expertise in the specific subject matter areas. The presentations will illustrate the importance of a multidisciplinary approach to solve difficult problems in thoracic disease. The target audience for this course includes pathologists, pulmonologists, thoracic surgeons, and radiologists, including physicians in training, in both academic and community settings. 

Learning Objectives

  • Evaluate individual tests and their tissue requirements for clinical management of advanced lung cancer patients.
  • Apply the updated staging guidelines for lung cancer.
  • Analyze current diagnostic criteria for mesothelioma, including a clinicopathological staging system.
  • Determine when to apply the international guidelines for the care of patients with interstitial lung disease.

Developed and Offered By:

  • Massachusetts General Hospital, Pathology Logo

Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Massachusetts General Hospital.

Who Should Participate

Physician Assistants, Nurse Practitioners, Industry, and Specialty Physicians

Schedule

All agenda sessions are in Eastern Time.

Day 1

Friday, October 2, 2026

Opening Remarks

Mari Mino-Kenudson

7:50-8:00 am

Updates in Classification and Diagnosis in Lung Cancer

William Travis

8:00-8:30 am

Updates in Lung Adenocarcinoma Variants and Squamous Cell Carcinoma

Mari Mino-Kenudson

8:30-9:00 am

Staging of Lung Cancer

Sanja Dacic

9:00-9:30 am

Q&A Session

William Travis; Mari Mino-Kenudson; Sanja Dacic

9:30-9:45 am

BREAK

9:45-10:00 am

Immunohistochemistry for Lung Cancer Diagnosis

natasha rekhtman

10:00-10:30 am

Diagnosis of Lung Cancer in Small Biopsies and Cytology

Paul VanderLaan

10:30-11:00 am

Clinically Relevant Molecular Profiles in Lung Cancer

Lynette Sholl

11:00-11:30 am

Interactive Session

Yin Hung; Angela Shih

11:30 am-12:00 pm

Q&A Session

Paul VanderLaan; Lynette Sholl; Yin Hung

12:00-12:15 pm

LUNCH BREAK

12:15-1:15 pm

Neuroendocrine Tumors of the Lung

natasha rekhtman

1:15-1:45 pm

Mesothelioma

Yin Hung

1:45-2:15 pm

Mediastinal Tumors: Thymoma and Germ Cell Tumors

Andre Moreira

2:15-2:45 pm

Q&A Session

natasha rekhtman; Yin Hung; Andre Moreira

2:45-3:00 pm

BREAK

3:00-3:15 pm

Current Update in Thoracic Oncology: Implications for Pathologists

Zofia Piotrowska

3:15-3:45 pm

What Does a Thoracic Surgeon Want to Know from Pathologists?

Hugh Auchincloss

3:45-4:15 pm

Tumor Board Discussion

Ibiayi Dagogo-Jack; Michael Lanuti; Mari Mino-Kenudson; Subba Digumarthy

4:15-4:45 pm

Q&A Session

4:45-5:00 pm

Day 2

Saturday, October 3, 2026

Pathology of Interstitial Lung Disease

William Travis

8:00-8:30 am

Radiology of Interstitial Lung Disease

Amita Sharma

8:30-9:00 am

Clinical Profile of Interstitial Lung Disease

Barry Shea

9:00-9:30 am

Q&A Session

9:30-9:45 am

BREAK

9:45-10:00 am

Bronchiolocentric Interstitial Pneumonia

Lida Hariri

10:00-10:30 am

The Pathologist's Role in Multidisciplinary Discussion for Interstitial Lung Disease

Lida Hariri

10:30-11:00 am

Diagnostic Approach to Acute Lung Injury

Angela Shih

11:00-11:30 am

Multidisciplinary Approach to Interstitial Lung Disease

Lida Hariri; Amita Sharma; Barry Shea

11:30 am-12:00 pm

Q&A Session

12:00-12:15 pm

LUNCH BREAK

12:15-1:15 pm

Pulmonary Infection Including COVID-Related Lung Disease

Angela Shih

1:15-1:45 pm

Pathology of Lung Transplantation

Robert Padera

1:45-2:15 pm

Pulmonary and Mediastinal Lymphomas

Aliyah Sohani

2:15-2:45 pm

Q&A Session

2:45-3:00 pm

BREAK

3:00-3:15 pm

Pitfalls in Intraoperative Consultation and QA Issues of Thoracic Diseases

Mari Mino-Kenudson

3:15-3:45 pm

Thoracic Soft Tissue Tumors

Yin Hung

3:45-4:15 pm

Mystery Cases

Marina Vivero

4:15-4:45 pm

Q&A Session and Course Conclusion

4:45-5:00 pm

Faculty

Harvard Medical School Continuing Education attracts the best and brightest faculty from all around the world. As a student in this course, you’ll have access to outstanding course directors and faculty.

 

Course Directors

Hugh Auchincloss, MD, MPH

John Chambers, BS

Hildreth Curran, BA

Sanja Dacic, MD, PhD

Ibiayi Dagogo-Jack, MD

Subba Digumarthy, MD

Michael Lanuti, MD

Andre Moreira, MD, PhD

Robert Padera, MD, PhD

Zofia Piotrowska, MD

Amita Sharma, MD

Barry Shea, MD

Angela Shih, MD

Lynette Sholl, MD

Aliyah Sohani, MD

Paul VanderLaan, MD, PhD

Marina Vivero, MD

Complete Your Registration

Started a registration? Log in to enroll today.

Log in to Access.

Request Information

Interested in learning more about this program? Sign up for details.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Course Fees

Registration Details

You may register through our secure online environment and will receive an email confirmation upon receipt of your payment. Prices include CME credit, electronic syllabus, and most recording are available for 90 days. At the end of the registration process, a $10 non-refundable processing fee will be added to your registration. 

Review the cancellation policy.

Early Registration Deadline:

Role Course Fee Early Registration Course Fee
Physician (MD/DO) $500 $400
Nurse (RN/APRN) $500 $400
PA $500 $400
Psychologist $500 $400
Resident/Fellow $350 $250
Social Worker $500 $400
Allied Health Professional / Other $500 $400

Accreditation

In support of improving patient care, Harvard Medical School is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

To receive CME/CE credit, learners are required to complete the course evaluation. Once the evaluation is complete, you will be able to claim your credit and download your certificate. All evaluations and credit claims must be completed within 60 days of the course end date.

The Harvard Medical School designates this live activity for a maximum of 15.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For the purpose of recertification, the American Academy of Nurse Practitioners Certification Board and American Nurses Credentialing Center accept  AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education). We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure. 

The National Commission on Certification of Physician Assistants (NCCPA) states that  AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.

The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialists (UEMS). Additional information regarding this agreement may be found on the Union of European Medical Specialists website.

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

Competencies

This course is designed to meet the following Institute of Medicine Core Competencies:

  • Work in Interdisciplinary Teams
  • Employ Evidence-Based Practice

This course is designed to meet the following American Board of Medical Specialties (ABMS) / Accreditation Council for Graduate Medical Educational (ACGME) competencies:

  • Medical Knowledge
  • Practice-Based Learning and Improvement

Disclaimer & Disclosure

CME activities accredited by Harvard Medical School are offered solely for educational purposes and do not constitute any form of certification of competency. Practitioners should always consult additional sources of information and exercise their best professional judgment before making clinical decisions of any kind.

Note: AMA PRA Category 1 Credit™ is calculated based on submission of a preliminary agenda and may be subject to change.

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education (ACCME), course planners, speakers, and content reviewers have been asked to disclose any relationships they have to companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Registration for courses managed by Harvard Medical School can only be completed through Harvard Medical School’s official registration portal: cmeregistration.hms.harvard.edu. Attendee registrations made through any other sites cannot be honored and will not be refunded. Please report any unauthorized websites or solicitations for registrations.

In order to comply with applicable U.S. export control and sanctions regulations, Harvard Medical School prohibits access to and use of Harvard Medical School educational offerings, programs and resources to individuals from certain sanctioned regions or who are otherwise subject to U.S. government sanctions, unless appropriate authorization is in place.

Program Topics